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ABSTRACT.
Purpose: ‘Type A’ behavioural characteristics and psychosocial stress have
traditionally been associated with chronic central serous chorioretinopathy
(cCSC). However, a characteristical personality profile could not be identified in
these patients and the presumed association with stress is subject to controversy,
due to a lack of convincing studies using validated measuring instruments. In this
study, we aimed to assess maladaptive personality traits, psychological morbidity
and coping strategies in patients with cCSC, in order to identify potentially
modifiable psychosocial aspects which could be used in support to current
standard treatment.
Methods: A cross-sectional study in a cohort of 86 patients with cCSC using
validated questionnaires. Findings were compared to both Dutch population
reference data and reference data from patients treated for Cushing’s disease.
Results: Maladaptive personality traits were not more prevalent in patients with
cCSC than in the general population, and psychological morbidity was not
increased. Patients with cCSC were shown to make more use of passive coping,
active coping and seeking social support. Interestingly, personality, psycholog-
ical morbidity and coping characteristics of patients with cCSC were more
comparable to features of patients treated for Cushing’s disease than to
population-based data.
Conclusion: Maladaptive personality traits such as type A behavioural
characteristics are not more prevalent in patients with cCSC. Patients with
cCSC make more use of certain coping strategies, which could be addressed
by psychosocial care to improve self-management. Further research is needed
establish whether the course of disease can be improved by altering coping
and reducing ‘stress’.
Key words: central serous chorioretinopathy – coping – cross-sectional study – irritability
personality – stress
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(CSC) is a specific and relatively com-
mon chorioretinal disease in which
choroidal congestion, thickening and
hyperpermeability damage the retinal
pigment epithelium and subsequently
induce serous subretinal fluid accumu-
lation and detachment of the neu-
roretina.
The pathogenesis of CSC is cur-
rently unclear, but many studies indi-
cate a pathophysiological association
with stress pathways, due to the rela-
tion with both exogenous and endoge-
nous corticosteroid excess, as well as
overactivity of the hypothalamus–pitu-
itary–adrenal (HPA) axis (Bouzas et al.
2002; Carvalho-Recchia et al. 2002;
Jonas & Kamppeter 2005; Wang et al.
2008; Gemenetzi et al. 2010; Liew et al.
2013; Nicholson et al. 2013; van Dijk
et al. 2016; van Haalen et al. 2018).
Both acute and chronic psychosocial
stress have been suggested to predis-
pose to CSC (Conrad et al. 2000;
Spahn et al. 2004). It has also been
suggested that people with a type A
behaviour pattern have an increased
risk to develop CSC (Jenkins et al.
1967; Yannuzzi 1987; Baraki et al.
2010; Chatziralli et al. 2017). The term
‘type A behaviour’ was introduced by
Friedman & Rosenman (1959) and was
characterized as follows: an intense,
sustained drive to achieve self-selected
but usually poorly defined goals,
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profound inclination and eagerness to
compete, persistent desire for recogni-
tion and advancement, continuous
involvement in multiple and diverse
functions constantly subject to deadli-
nes, habitual propensity to accelerate
the rate of execution of many physical
and mental functions, and extraordi-
nary mental and physical alertness. The
concept of personality types has been
studied in medical psychology as a
predictor of the cause, course and
quality of life of somatic diseases such
as cancer, rheumatic diseases and coro-
nary artery disease (Dalton et al. 2002;
Hausteiner et al. 2010; Donisan et al.
2017). It has been hypothesized that
type A behaviour might be linked to
CSC by increased levels of circulating
catecholamines and corticosteroids,
since these hormone levels are found
to be higher in people with type A
behavioural characteristics compared
to those with type B behavioural char-
acteristics (more relaxed and less hur-
ried) (Friedman et al. 1960, 1975;
Rosenman et al. 1976; Williams et al.
1982). A recent meta-analysis indeed
concluded that patients with CSC
demonstrated significantly more type
A behavioural characteristics than
healthy controls (odds ratio
(OR) = 2.53; confidence interval (CI)
1.08–5.96) (Liu et al. 2016). Despite
this proposed association between CSC
and type A behavioural characteristics
(Yannuzzi 1987), a typical CSC per-
sonality profile could not be identified
in previous studies. Only type A
behavioural characteristics have been
previously observed (Bahrke et al.
2000).
It is well known that personality
affects coping behaviour (Friedman
et al. 2006). Coping behaviour encom-
passes the way people react on a
behavioural, cognitive and emotional
level to situations that require adjust-
ments in dealing with possible adverse
events (Schreurs et al. 1993), which has
an effect on the amount of stress
experienced (Ersan et al. 2017). Speci-
fic coping styles (e.g. emotion-oriented
coping) have even been reported to
have an effect on disease severity, for
example in multiple sclerosis (Brands
et al. 2017). For CSC, several mostly
small-sized studies have reported an
association between severe psychoso-
cial stressful events and the onset of
disease, with one study describing this
association especially in patients with
poor coping mechanisms (Conrad
et al. 2000; Spahn et al. 2004; Lahou-
sen et al. 2016). However, coping
behaviour may be a valuable starting
point for psycho-education or self-
management training in order to
improve quality of life. Also psycho-
logical morbidity such as apathy or
irritability may be a potential point of
engagement for self-management pro-
grammes. To date, these psychological
factors have not been evaluated in CSC
patients.
To the best of our knowledge, no
previous systematic studies have been
published assessing personality traits
in patients with CSC, and there are no
studies in a large cohort of patients
with CSC that have systematically
evaluated coping strategies using a
specific coping-oriented validated
questionnaire. Since CSC seems to be
related to stress (Bouzas et al. 2002;
Carvalho-Recchia et al. 2002; Jonas &
Kamppeter 2005; Wang et al. 2008;
Gemenetzi et al. 2010; Liew et al.
2013; Nicholson et al. 2013; van Dijk
et al. 2016; van Haalen et al. 2018), a
detailed assessment of potential asso-
ciations with personality traits, psy-
chological morbidity and coping
mechanisms is essential to identify
potentially psychosocial aspects that
could be modifiable with self-manage-
ment programmes.
The primary aim of this study was to
assess maladaptive personality traits
(i.e. traits related to type A behavioural
pattern), in patients with cCSC. For
this purpose, we compared personality
traits of patients with cCSC to person-
ality traits of Dutch population refer-
ence data, but also to personality traits
of patients treated for Cushing’s dis-
ease (since these patients were exposed
to excessive HPA - axis activity). In
addition, this study aimed to assess
psychological morbidity (i.e. apathy
and irritability) and coping strategies
in patients with cCSC by comparing
these patients with the same reference
groups. Finally, we aimed to assess the
association between personality and
coping in patients with cCSC. Since
previous studies have pointed towards
a higher prevalence of type A beha-
vioural characteristics in patients with
cCSC and considering the above-men-
tioned definition of type A behaviour
(Friedman & Rosenman 1959), we
assessed whether patients with cCSC
report more stimulus seeking,
callousness, rejection, conduct prob-
lems and narcissism. Furthermore,
considering the recently described
hyperactivity of the HPA axis in
patients with cCSC (van Haalen et al.
2018) and the previously described
maladaptive personality traits in
patients exposed to hypercortisolism
(i.e. Cushing’s disease) (Tiemensma
et al. 2010a,b), we hypothesized that
patients with CSC would report more
maladaptive personality traits, more
psychological morbidity (i.e. apathy,
irritability) and less effective coping
strategies compared to reference data
from the general population. In accor-
dance with previous literature in
patients with other chronic diseases
(Schouws et al. 2015; Vollmann et al.
2016; Keramat Kar et al. 2017; Yadav
et al. 2017; You et al. 2018), we
hypothesized that more maladaptive
personality traits are associated with




We conducted a cross-sectional study
in a cohort of patients with cCSC.
Patients were asked to complete a set of
validated questionnaires on personality
traits, psychological morbidity (i.e.
apathy and irritability) and coping
strategies at home, using an online
survey. In addition, a clinical evalua-
tion took place during a single visit to
the outpatient clinic of the Division of
Endocrinology of the Leiden Univer-
sity Medical Center.
Study population
Eighty-six consecutive adult patients
with cCSC, who were followed at the
Department of Ophthalmology of Lei-
den University Medical Center, a ter-
tiary referral center for CSC, were
invited to complete the questionnaires.
The cCSC diagnosis had been con-
firmed by fundoscopy, digital colour
fundus photography (Topcon Corp.,
Tokyo, Japan), fundus autofluores-
cence (Spectralis Heidelberg retinal
angiography (HRA) + optical coher-
ence tomography (OCT); Heidelberg
Engineering, Heidelberg, Germany),
spectral-domain OCT (Spectralis
HRA + OCT), fluorescein angiogra-
phy (Spectralis HRA + OCT) and
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indocyanine green angiography (Spec-
tralis HRA + OCT), according to cur-
rent standards (Wang et al. 2008;
Gemenetzi et al. 2010; Yannuzzi 2010;
Liew et al. 2013; Nicholson et al. 2013;
Daruich et al. 2015). On multimodal
imaging, the following characteristics
had to be present within the past
2 years: serous subretinal fluid on
OCT, ≥1 area of multifocal diffuse
leakage or irregular retinal pigment
epithelium window defects on fluores-
cein angiography, and corresponding
hyperfluorescence on indocyanine
green angiography. Patients were
divided into active or nonactive cCSC
at the moment of evaluation, defined
by the presence of subretinal fluid. We
excluded patients diagnosed with acute
CSC, defined by either a focal leakage
spot or a smoke stack pattern on
fluorescein angiography (Wang et al.
2008; Gemenetzi et al. 2010; Yannuzzi
2010; Liew et al. 2013; Nicholson et al.
2013; Daruich et al. 2015), as well as
patients in whom evidence of other
retinal diagnoses was detected. The
patients also participated in a study
on endocrinological phenotyping
focussed on the HPA axis (data pre-
sented elsewhere) (van Haalen et al.
2018), for which other exclusion crite-
ria were the use of corticosteroids or
sleep medication prior to the develop-
ment or during the time-course of
cCSC, excessive alcohol intake
(>21 units/week), either night shift
work or travelling from another time
zone in the 6 weeks prior to evaluation.
Endocrinological evaluation of the
patients included a detailed medical
history and complete physical exami-
nation and was performed by two
endocrinologists. After reassessment
of the retinal imaging by two indepen-
dent ophthalmologists, five patients
were considered to have less typical
cCSC findings on imaging. Written
informed consent was obtained from
all participants, and approval of the
institutional review board and the
ethics committee was obtained
(NL50816.058.14). Research was con-
ducted following the tenets of the
Declaration of Helsinki.
Questionnaires
Dimensional assessment of personality
pathology short form
This questionnaire consists of 136
items assessing personality, which are
subdivided into 18 subscales: submis-
siveness, cognitive distortion, identity
problems, affective lability, stimulus
seeking, compulsivity, restricted
expression, callousness, oppositional-
ity, intimacy problems, rejection,
anxiousness, conduct problems, suspi-
ciousness, social avoidance, narcissism,
insecure attachment and self-harm (van
Kampen et al. 2008; de Beurs et al.
2009). The maximal scores for each
subscale differ from 30 to 40, and
higher scores indicate more pro-
nounced maladaptive personality
traits. No formal cut-off scores for
these subscales exist (van Kampen
et al. 2008; de Beurs et al. 2009). We
hypothesized that if type A behavioural
characteristics would be more preva-
lent in patients with cCSC, these
patients would report more stimulus
seeking, callousness, rejection, conduct
problems and narcissism.
Apathy Scale
The Apathy Scale (AS) of Starkstein
was used to assess apathy (Starkstein
et al. 2001). The scale consists of 14
questions on a four-point scale, mea-
suring different features of apathy in
the two previous weeks. Total scores in
a range from 0 to 42 points are
calculated, with higher scores indicat-
ing greater apathy. A total score of 14
points or more defines apathy (Chat-
terjee et al. 2005).
Irritability Scale
Irritability was assessed by the Irri-
tability Scale (IS) (Chatterjee et al.
2005). This scale consists of 14 items
on a four-point scale, assessing differ-
ent features of irritability in the two
previous weeks. Total scores range
from 0 to 42 points, with higher scores
indicating greater irritability. A total
score of 14 points or more defines
irritability.
Utrecht Coping Scale
The Utrecht Coping Scale (UCS) is an
established Dutch coping list with well-
documented validity and reliability
(Hopman-Rock et al. 1997). It con-
tains 47 statements where one indicates
whether he/she finds these applicable to
him- or herself. This scale assesses the
way a person acts to minimize the
impact of stressful events, with seven
subscales that represent different cop-
ing styles. These subscales include
active coping (i.e. immediate action in
case of problems, considering problems
as a challenge, keeping calm, goal-
oriented problem-solving), distraction-
seeking, avoidance, seeking social sup-
port, passive coping (i.e. isolation,
worrying about the past, using sooth-
ing resources, fleeing in fantasies),
expression of emotions, and positive
reframing (i.e. optimism, trying to
reconsider things in a positive light).
The different items have a four-point
scale ranging from 1 (seldom or never)
to 4 (very often). Item scores on each
subscale are summed to create a total
score, with scores of 4 or 5 indicating
high use of that specific coping style
(Schreurs et al. 1984). Data from an a-
select sample of the Dutch railway
workers (1493 men, aged between 19
and 65 years) were used as reference
data. A cohort of 42 Cushing’s disease
patients (six men and 36 women) with a
mean age of 54 (12) years was used
for comparison (Tiemensma et al.
2011).
Reference data
Outcomes of the questionnaires were
compared to reference of a random
sample of the Dutch population and
reference data from patients treated for
Cushing’s disease as reported previ-
ously by Tiemensma et al. (2010a,b,
2011). For comparison of dimensional
assessment of personality pathology
short form (DAPPsf) outcomes, refer-
ence data from the publisher of this
questionnaire were available (Dirk van
Kampen 2009). The sample used for
obtaining these data consisted of 58
men aged 15–34 years, 94 men aged
35–54 years, 146 women aged
15–34 years and 172 women aged 35–
54 years. The sample of patients trea-
ted for Cushing’s disease used for
comparison consisted of eight men
and 43 women with a mean age of 53
(13) years (Tiemensma et al. 2010a,
b). Concerning the AS and IS, refer-
ence data were derived from the
healthy control population described
by Tiemensma et al. (2010a,b) consist-
ing of 35 men and 33 women with a
mean age of 59 (11) years. No male-
only reference data were available. The
same cohort of patients with Cushing’s
disease was used for the comparison of
the AS and IS scores (Tiemensma et al.
2010a,b). Data from a random sample
of the Dutch railway workers (1493
men, aged between 19 and 65 years)
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were used as reference data for the
comparison of UCS outcomes. More-
over, the cohort of 42 patients treated
for Cushing’s disease (six men and 36
women) with a mean age of 54 (12)
years was used for comparison (Tie-
mensma et al. 2011).
Statistical analysis
Data were presented as mean and
standard deviation (SD), unless men-
tioned otherwise. The primary analyses
comprised the comparison of question-
naire outcomes between patients with
cCSC and reference data from the
general population. Secondary analyses
comprised the comparison between
patients with cCSC and patients trea-
ted for Cushing’s disease. Groups were
compared using pooled t-tests. The
level of significance was set at
p ≤ 0.01 in order to correct for multi-
ple testing. Normality of data was
tested using the Shapiro–Wilk test.
Correlations between personality and
coping were assessed using Pearson’s
correlation in case of normally dis-
tributed data, and data with a non-
normal distribution were correlated
using Spearman correlation. Only
moderate-to-strong correlations (corre-
lation coefficient of >0.5) were
described.
A post hoc sensitivity analysis
excluding the five less typical cCSC
patients was performed. Data were
analysed using SPSS Statistics (version




A total of 86 patients with cCSC (77
males [90%]) with a mean age of
48.7 years (range, 24–77 years) were
included. In all patients, subretinal
fluid had been present <2 years ago.
In 58 patients with cCSC (67%), sub-
retinal fluid was present at the moment
of evaluation, indicating active cCSC.
The mean duration from first cCSC
diagnosis at an ophthalmologist to
inclusion in our study was 3.9 years
(range, 0.2–37.1 years). A history of
hypertension was reported by 23
patients (27%), dyslipidaemia by 18
patients (21%) and psychiatric disor-
ders by 16 patients (19%) (Table 1).
Apart from being slightly overweight
(mean body mass index 26.2 kg/m2),
patients appeared to be healthy on
physical examination, with a mean
blood pressure within the normal
range. None of the patients fulfilled
the criteria for Cushing’s syndrome.
Personality traits
Dimensional assessment of personality
pathology short form
The DAPPsf was completed by 81
patients with cCSC (94%). Compared
to reference data from the general
population, patients with cCSC
reported only more intimacy problems
(p < 0.01), but less submissiveness
(p < 0.01), less cognitive distortion (p
< 0.01), less affective lability (p <
0.01), less stimulus seeking (p < 0.01),
less compulsivity (p < 0.01), less oppo-
sitionality (p < 0.01), less anxiousness
(p < 0.01), less suspiciousness
(p < 0.01), less social avoidance
(p < 0.01), less narcissism (p < 0.01)
and less insecure attachment
(p < 0.01) (Table 2 and Fig. 1). Inter-
estingly, there was no increased preva-
lence of type A behavioural
characteristics in patients with cCSC
(i.e. no more stimulus seeking, callous-
ness, rejection, conduct problems and
narcissism).
Compared to patients treated for
Cushing’s disease, patients with cCSC
reported more conduct problems
(p < 0.01), but less affective lability
(p < 0.01), less cognitive distortion
(p < 0.01) and less oppositionality
(p < 0.01). For the remaining person-
ality traits, no large difference was
observed between patients with cCSC
and patients treated for Cushing’s dis-
ease.
Compared to patients with active
cCSC (n = 54), patients with inactive
disease (n = 27) reported more affective
lability, submissiveness and social
avoidance (p < 0.01, p < 0.01 and
p < 0.01, respectively).
Psychological morbidity
The AS was completed by 83 patients
with cCSC (97%) (Table 3). The mean
score of patients with cCSC was 12.2
(range, 3–26). Clinically relevant apa-
thy (a score of ≥14) was present in
34.9% of the patients with cCSC. No
differences in reported apathy were
found between patients with cCSC
and the reference data from the general
population, and the apathy score was
lower than scores of patients treated
for Cushing’s disease (p = 0.03 and
p = 0.01, respectively). Although no
significant differences were found, the
scores of patients with cCSC were in
between the scores of the reference data
from the general population and the
reference data from patients treated for
Cushing’s disease (Fig. 2). No differ-
ence was observed in total scores
between patients with active cCSC
and patients with inactive disease
(p = 0.26).
The IS was also completed by 83
patients with cCSC (97%) (Table 3).
Mean patient score was 9.8 (range, 0–
26). Clinically relevant irritability (a
score of ≥14) was present in 29.3% of
patients with cCSC. No differences in
Table 1. Clinical characteristics of chronic central serous chorioretinopathy (cCSC) patients.
cCSC patients
n = 86
Mean age, years (SD) 48.7 (10.8)
Sex, male/female 77/9
Duration of cCSC disease, years (range) 3.9 (0.2–37.1)
History of hypertension, n (%) 23 (26.7%)
History of diabetes mellitus, n (%) 6 (7.0%)
History of dyslipidaemia, n (%) 18 (20.9%)
History of psychiatric disorders*, n (%) 16 (18.6%)
History of thromboembolic events, n (%) 0 (0%)
History of cardiac events†, n (%) 5 (5.9%)
History of sexual disorders‡, n (%) 19 (22.1%)
SD = standard deviation.
* Consisting of depression, anxiety or panic disorder, posttraumatic stress disorder, burnout,
alcohol abuse and schizophrenia.
† Consisting of myocardial infarction, endocarditis and atrial fibrillation.
‡ Consisting of impotence, hirsutism, menstrual cycle disorders and loss of libido.
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reported irritability were observed
between patients with cCSC and the
reference data from the general popu-
lation (p = 0.79), nor to reference data
from patients treated for Cushing’s
disease (p = 0.15). Although no statis-
tically significant differences were
found, the scores of patients with cCSC
were in between the scores of the
reference data from the general popu-
lation and the reference data from
patients treated for Cushing’s disease,
which was in line with the outcome of
the assessment of apathy (Fig. 2).
Total scores did not differ between
patients with active cCSC and patients
with inactive cCSC (p = 0.36).
Coping strategies
Eighty-three patients with cCSC (97%)
completed the UCS (Table 4). Com-
pared to the reference data, patients
with cCSC reported to use more pas-
sive coping strategies and to seek more
social support (p < 0.01 and p < 0.01,
respectively). Because the reference
data were male only, data from male
patients with cCSC between 19 and
65 years of age (n = 67) were compared
separately. This category of patients
with cCSC made more use of active
coping compared to the reference pop-
ulation (p < 0.01), in addition to the
aforementioned seeking social support
(p < 0.01) and passive coping
(p < 0.01). Patients with inactive dis-
ease (n = 27) made more use of
avoiding compared to cCSC patients
with active disease (n = 56, p < 0.01).
No differences in coping strategies were
observed between patients with cCSC
and patients treated for Cushing’s dis-
ease.
Correlation between personality and
coping strategies in cCSC
Moderate-to-strong correlations were
found between several maladaptive
personality traits and passive coping.
More affective lability (p < 0.01,
R2 = 0.759), cognitive distortion
(p < 0.01, R2 = 0.656), identity prob-
lems (p < 0.01, R2 = 0.675), insecure
attachment (p < 0.01, R2 = 0.558),
oppositionality (p < 0.01, R2 = 0.522),
social avoidance (p < 0.01, R2 = 0.515)
and anxiousness (p < 0.01, R2 = 0.711)
correlated with using more passive
coping.
Post hoc analysis without patients with less
typical cCSC
Analyses performed without the five
patients with atypical cCSC revealed
only a few minor differences. These
results are shown in Appendix S1.
Discussion
In this study, personality traits, psy-
chological morbidity and coping strate-
gies were systematically assessed in a
cohort of patients with cCSC. We did
not find a higher prevalence of mal-
adaptive personality traits such as type
A behavioural characteristics in cCSC
as compared to the general population,
which is in contrast to what has been
suggested previously (Yannuzzi 1987;
Baraki et al. 2010; Liu et al. 2016;
Chatziralli et al. 2017). On the level of
conduct, patients did not report more
psychological morbidity in the form of
apathy or irritability. Patients with
cCSC made more use of certain coping
strategies (e.g. seeking social support,
passive coping, and in males also active
coping) compared to the general pop-
ulation.
In contrast to earlier studies sug-
gesting more type A behavioural char-
acteristics (i.e. persistent desire for
recognition and advancement, and
habitual propensity to accelerate the
rate of execution of many physical and
mental functions) in these patients
(Yannuzzi 1987; Baraki et al. 2010;
Liu et al. 2016; Chatziralli et al.
2017), we did not find any evidence to
support this. Critical evaluation of the
available literature revealed that type A
behavioural characteristics were mainly
assessed using behavioural outcome
measures (i.e. Jenkins activity survey)
in previous studies (Yannuzzi 1987;
Baraki et al. 2010; Liu et al. 2016;
Chatziralli et al. 2017), while this
inventory has been shown not to cor-
relate with personality characteristics
and psychopathology (Wadden et al.
1983). In another study, type A
Table 2. Personality traits in chronic central serous chorioretinopathy (cCSC).
DAPPsf cCSC patients (n = 81) Reference data (n = 475) p-Value Cushing’s disease patients (n = 51) p-Value
Submissiveness 16.2 (6.6) 19.7 (6.3) <0.01 19.0 (7.7) 0.03
Cognitive distortion 9.0 (4.3) 12.1 (5.4) <0.01 11.5 (5.6) <0.01
Identity problems 10.6 (4.7) 12.2 (5.6) 0.02 13.0 (6.6) 0.01
Affective lability 16.5 (6.9) 21.0 (7.3) <0.01 21.7 (7.8) <0.01
Stimulus seeking 15.2 (5.4) 18.0 (5.8) <0.01 16.4 (4.8) 0.19
Compulsivity 21.9 (7.1) 24.2 (6.5) <0.01 23.8 (6.6) 0.12
Restricted expression 20.9 (5.9) 21.3 (6.5) 0.65 21.2 (7.3) 0.80
Callousness 17.2 (5.2) 18.8 (5.4) <0.01 16.1 (4.5) 0.23
Oppositionality 19.0 (7.0) 23.1 (7.2) <0.01 22.9 (8.8) <0.01
Intimacy problems 20.9 (5.9) 16.9 (5.7) <0.01 18.8 (6.4) 0.06
Rejection 19.3 (6.7) 20.1 (5.7) 0.28 17.2 (5.7) 0.06
Anxiousness 12.8 (6.2) 17.8 (5.7) <0.01 15.3 (6.2) 0.03
Conduct problems 10.8 (4.8) 11.5 (4.4) 0.21 9.0 (1.8) <0.01
Suspiciousness 12.7 (5.4) 15.0 (5.9) <0.01 12.6 (5.9) 0.96
Social avoidance 11.0 (5.2) 13.8 (5.5) <0.01 12.3 (6.3) 0.20
Narcissism 15.7 (5.7) 18.7 (6.2) <0.01 15.0 (5.5) 0.47
Insecure attachment 10.9 (4.9) 13.7 (5.6) <0.01 13.3 (6.6) 0.02
Self-harm 7.0 (2.7) 8.0 (4.2) 0.05 7.3 (2.9) 0.58
Data are presented as mean (SD).
cCSC = chronic central serous chorioretinopathy; DAPPsf = Dimensional assessment of personality pathology short form; SD = standard deviation.
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behavioural characteristics were not
strictly defined, as the term itself may
have appeared in the medical charts or
patients were included as being type A
based on a description of patients by
themselves, family members or physi-
cians as being ‘tense’, ‘high strung’ or
‘highly ambitious’ (Breukink et al.
2017). The conclusion of a recent
meta-analysis suggesting more type A
behavioural characteristics in patients
with cCSC was based on these small
studies lacking a type A phenotyping
protocol, making the conclusion less
reliable (Liu et al. 2016).
The fact that patients with cCSC
seem to report more intimacy problems
was interpreted as a chance finding,
since all the other traits point in the
opposite direction, with generally less
maladaptive personality traits in
patients with cCSC compared to the
general population. Interestingly, the
personality profile of patients with
cCSC in our cohort tended towards
more similarities with the profile of
patients treated for Cushing’s disease
than to the general population, since 14
out of the 18 DAPPsf subscales out-
comes of patients with cCSC were
comparable with outcomes of patients
treated for Cushing’s disease, where
only eight out of 18 were comparable
with the general population (Fig. 1,
with lines resembling patients with
cCSC in between the lines correspond-
ing with reference data of the general
population and patients treated for
Cushing’s disease). However, these
findings were not statistically signifi-
cant.
Cushing’s disease is a rare condition
which is characterized by exposure to
excessive cortisol levels. Therefore,
these patients can be regarded as a
human model to study the effects of
cortisol excess on personality and
behaviour. Maladaptive personality
traits and psychological morbidity,
such as somatic arousal, negative
affect, irritability and apathy, have well
been documented in patients with
Cushing’s disease (Tiemensma et al.
2010a,b). Patients with cCSC showed
less affective lability, cognitive distor-
tion and oppositionality compared to
patients treated for Cushing’s disease,
whereas they reported more conduct
problems, although the significance of
this difference was omitted in the post
hoc analysis excluding patients with
less typical cCSC. Apathy and irritabil-
ity scores of patients with cCSC in our
cohort were lower, yet not statistically
significant compared to scores of
patients treated for Cushing’s disease.
We have recently demonstrated that
patients with cCSC have an activated
HPA axis in the presence of high
normal serum levels of cortisol (van
Haalen et al. 2018). In line with
this biochemical resemblance of an
Fig. 1. DAPPsf personality traits in patients with cCSC. Data are presented as mean and SD.
cCSC = chronic central serous chorioretinopathy; DAPPsf = Dimensional assessment of person-
ality pathology short form; SD = standard deviation; *=statistically significant (defined as p-value
<0.01).




data (n = 68) p-Value
Cushing’s
disease patients
(n = 51) p-Value
Apathy 12.2 (5.0) 10.5 (4.8) 0.03 14.8 (6.5) 0.01
Irritability 9.8 (6.2) 9.5 (5.7) 0.79 11.5 (7.7) 0.15
Data are presented as mean (SD).
cCSC = chronic central serous chorioretinopathy; SD = standard deviation.
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activated HPA axis in both patient
groups, with patients with Cushing’s
disease at the far end of the spectrum of
HPA - axis activation and patients with
cCSC showing a slightly activated HPA
axis, the present study showed theremay
also be similarity between patients with
cCSC and patients treated for Cushing’s
disease regarding the spectrum of per-
sonality features. Despite this relative
degree of similarity, there was no statis-
tically significant difference in the tested
personality traits between the current
cCSC cohort and a healthy general
population. In literature, a possible
association between the occurrence of
CSC and a combination of stressful life
events and unfavourable coping styles
has been reported, with patients with
acuteCSC reportingmore unfavourable
stress coping compared to patients with
cCSC (Lahousen et al. 2016). Our cur-
rent data suggest that patients with
cCSC seek more social support. This
may be explained by the fact that cCSC
results in visual impairment affecting
quality of life (Breukink et al. 2017),
which makes patients more dependent
on others. Moreover, patients with
cCSC reported to use more active cop-
ing, but also more passive coping.
Although thismay seem to be somewhat
counterintuitive, it should be noted that
coping behaviour is situation depen-
dent, so that individuals can adapt their
coping strategy based on the situation
(Lazarus & Folkman 1984).
The comparison of validated ques-
tionnaires outcome of a large cohort of
patients with cCSC with both healthy
controls and a cohort of patients
treated for Cushing’s disease enabled
to describe personality traits, psycho-
logical morbidity and coping strategies
within a broad spectrum of HPA - axis
activity. Nevertheless, to find an ideal
control group is challenging and the
lack of a gender- and age-matched
control group can be considered a
potential limitation of this study. How-
ever, population-based reference data
were available and considered to be a
worthy alternative, since these data
were derived from large population-
based cohorts (Dirk van Kampen
2009). The gender and age distribution
of our cohort is in accordance with
available literature (Liew et al. 2013;
Daruich et al. 2015). Yet, since the
majority of our population is male
(90%), our results may not be general-
izable to female patients with cCSC.
This study aimed to investigate person-
ality traits in patients with cCSC, and
with the validated questionnaires used,
we did not find an association with type
A behavioural characteristics in these
patients.
Using validated measures, we found
no evidence for a higher prevalence of
maladaptive personality traits such as
type A behavioural characteristics in
patients with cCSC, nor any clear
differences in the generic personality
traits as compared to the general pop-
ulation. This finding is of interest, as
ophthalmologists often assume and
report stress-related and type A beha-
vioural characteristics in patients with
cCSC, and therefore, the advice on
stress reduction to these patients
appears common in their management
strategies (Gemenetzi et al. 2010; Rou-
vas et al. 2014; Goldhagen & Gold-
hardt 2017). However, our paper
indicates that psychological interven-
tions targeting these personality fea-
tures in cCSC, as was suggested in
previous literature (Yannuzzi 1986;
Conrad et al. 2014), may not be useful.
The results of the present study con-
tribute to the psychological phenotyp-
ing of patients with cCSC, which may
be used to design disease-specific sup-
port programmes that address coping
mechanisms in patients with cCSC.
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